Pizzuti Dana bought CRNX
October 1, 2025 · Form 4 insider transaction
Pizzuti Dana bought 5,000 shares of Crinetics Pharmaceuticals Inc at $16.89 per share, a transaction worth $84.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$16.89
Total value
$84.5K
InsiderPizzuti Dana
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 1, 2025
Filing dateOctober 3, 2025
Shares owned after71,270
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On September 4, 2025, the Reporting Person filed a Form 4 (the "Prior Form 4") which inadvertently reported that, following the transactions reported in the Prior Form 4, the Reporting Person directly owned 96,270 shares of the Issuer's common stock. In fact, the Reporting Person directly owned 66,270 shares of the Issuer's common stock following the transactions reported in the Prior Form 4.